SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that COVID-19 RT-PCR testing volume has increased in 2022 ...

According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, typhoid fever, shigellosis, meningitis and other viral haemorrhagic fevers ...

The partnership expands BioIQ’s fully integrated healthcare services to include Biomeme’s on-site testing platform to provide accurate, real-time RT-PCR COVID-19 test results with centralized access ...

Here, we describe a simple test for detection of SARS-CoV-2. The sensitivity of this test is similar to that of reverse-transcription–quantitative polymerase-chain-reaction (RT-qPCR) assays. STOP ...

During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

The accuracy of the RT-PCR test depends on timing; tests are best given within 10 days of COVID-19 symptom development. As the COVID-19 pandemic continues to spread across the country, many nurse ...